Sigyn Therapeutics reduces authorized common shares to 100M via charter amendment

Sigyn Therapeutics, Inc.

Filed Certificate of Amendment decreasing authorized common stock to 100 million shares (par value $0.0001).
Authorized preferred stock unchanged at 10 million shares (par value $0.0001).
Amendment effective upon filing on December 30, 2024.
No other changes to the Amended and Restated Certificate of Incorporation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.